2019
DOI: 10.1016/j.heliyon.2019.e02738
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, X-ray crystal structure, Hirshfeld surface analysis, and molecular docking study of novel inhibitor of hepatitis B: methyl 4-fluoro-3-(morpholinosulfonyl)benzo[b]thiophene-2-carboxylate

Abstract: A method of 4-fluoro-3-(morpholinosulfonyl)benzo[b]thiophene-2-carboxylate synthesis has been developed and the electronic and spatial structure of a new biologically active molecule has been studied both theoretically and experimentally. The title compound was crystallized from acetonitrile and the single crystal X-ray analysis has revealed that it exists in a monoclinic P21/c space group, with one molecule in the asymmetric part of the unit cell. Hirshfeld surface analysis was used to study intermolecular in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
3
0
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 12 publications
(4 citation statements)
references
References 28 publications
(33 reference statements)
0
3
0
1
Order By: Relevance
“…Heterocyclic homologues of 2H-1,2,6-thiadiazine-1,1-dioxides are inhibitors of human cytomegalovirus (Martínez et al, 2003), Cruzi triposome (Á lvarez et al, 2010) and diuretics (Goya et al, 1992). In a continuation of our efforts to obtain new HBV inhibitors for the treatment and prevention of human HBV infections (Ivachtchenko et al, 2019;Ivashchenko et al, 2019;Kovalenko et al, 2019), we initiated the design, synthesis, and anti-hepatitis B virus activity testing of the new 2H-1,2,6thiadiazine 1,1-dioxide derivative, ethyl 5-methyl-1,1-dioxo-2-{[5-(pentan-3-yl)-1,2,4-oxadiazol-3-yl]methyl}-2H-1,2,6-thiadiazine-4-carboxylate (3).…”
Section: Chemical Contextmentioning
confidence: 99%
“…Heterocyclic homologues of 2H-1,2,6-thiadiazine-1,1-dioxides are inhibitors of human cytomegalovirus (Martínez et al, 2003), Cruzi triposome (Á lvarez et al, 2010) and diuretics (Goya et al, 1992). In a continuation of our efforts to obtain new HBV inhibitors for the treatment and prevention of human HBV infections (Ivachtchenko et al, 2019;Ivashchenko et al, 2019;Kovalenko et al, 2019), we initiated the design, synthesis, and anti-hepatitis B virus activity testing of the new 2H-1,2,6thiadiazine 1,1-dioxide derivative, ethyl 5-methyl-1,1-dioxo-2-{[5-(pentan-3-yl)-1,2,4-oxadiazol-3-yl]methyl}-2H-1,2,6-thiadiazine-4-carboxylate (3).…”
Section: Chemical Contextmentioning
confidence: 99%
“…Линейные зависимости между длинами связей и параметрами электронной плотности в критических точках (КТ) связевых путей при взаимодействии меди с тиофеном, легированном металлами получены в [17]. Изучению КТ связующих линий между тиофеном и другими веществами посвящены материалы [18], а также производных тиофена [19]. Несмотря на широкое использование QTAIM при исследовании тиофена и его соединений, интегральные электронные характеристики атомов и групп (заряд, энергия и объем) ранее рассмотрены не были.…”
Section: Introductionunclassified
“…The disadvantages of nucleoside analogs prompted us and other researchers to invent and find new structural non-nucleoside analog compounds [11][12][13][14][15][16]. Many anti-HBV bioactive non-nucleoside analog compounds have been designed and developed on the basis of their interactions with receptor using molecular docking [17][18][19][20][21]. When HBV receptor binding domain PreS1 and PreS2 protein (including L protein, M protein and S protein) interact with small molecules, the virus will not allow entry to hepatocyte.…”
Section: Introductionmentioning
confidence: 99%